Effects of 12 months rhGH treatment on bone and collagen turnover in children with constitutional growth delay

Journal of Pediatric Endocrinology and Metabolism

Volumn 12, Issue 6, 1999, Pages 833-838

  Sartorio, A ^a   Conti, A ^a   Ferrero, S ^a   Saraifoger, S ^a   Resnik, M ^a   Baroncelli, G I ^b  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Bone; Collagen; Constitutional growth delay; Deoxypyridinoline; Growth hormone; Osteocalcin; Telopeptide

Indexed keywords

COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CREATININE; DEOXYPYRIDINOLINE; HUMAN GROWTH HORMONE; OSTEOCALCIN; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE;

ARTICLE; BONE REMODELING; BONE TURNOVER; CHILD; CLINICAL ARTICLE; COLLAGEN METABOLISM; COLLAGEN SYNTHESIS; DISEASE ASSOCIATION; GROWTH RETARDATION; HORMONAL THERAPY; HUMAN; MALE; OSTEOBLAST; OSTEOLYSIS; SHORT STATURE;

EID: 0033454052     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.1999.12.6.833     Document Type: Article

References (20)

1. Bouillon R. Growth hormone and bone. Horm Res 1991; 36 (Suppl 1): 49-55.
2. Brixen K, Nielsen HK, Mosekilde L, Flyvbjerg A. A short course of recombinant human growth hormone treatment stimulates osteoblast and activates bone remodelling in normal human volunteers. J Bone Min Res 1990; 5: 609-618.
3. Ernst M, Froesch ER. Growth hormone dependent stimulation of osteoblast-like cells in serum-free cultures via local synthesis of insulin-like growth factor I. Biochem Biophys Res Comm 1988; 151: 142-147.
4. Hock JM, Centrella M, Canalis E. Insulin-like growth factor I has independent effects on bone matrix formation and cell replication. Endocrinology 1988; 122: 254-260.
5. Johansen JS, Giwercman A, Hartwell D, Nielsen CT, Price PA, Christiansen C, Skakkebaek NE. Serum bone-GLA protein as a marker of bone growth in children and adolescents: correlation with age, height, serum insulin-like growth factor I, and serum testosterone. J Clin Endocrinol Metab 1988; 67: 273-278.
6. Sartorio A, Conti A, Guzzaloni G, Faglia G. Serum osteocalcin levels in patients with GH deficiency before and during GH treatment. Acta Paediatr Scand 1991; 80: 100-102.
7. Saggese G, Baroncelli GI, Bertelloni S, Cinquante L, Di Nero G. Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency. J Pediatr 1993; 122: 37-45.
8. Sartorio A, Conti A, Monzani M. New markers of bone and collagen turnover in children and adults with growth hormone deficiency. Postgrad Med J 1993; 69: 846-850.
9. Kanzaki S, Hosoda K, Moriwake T, Tanaka H, Kubo T, Inoue M, Higuchi J, Yamaji T, Seino Y. Serum propeptide and intact molecular osteocalcin in normal children and children with growth hormone (GH) deficiency: a potential marker of bone growth and response to GH therapy. J Clin Endocrinol Metab 1992; 75: 1104-1109.
10. Fujimoto S, Kubo T, Tanaka H, Miura M, Seino Y. Urinary pyridinoline and deoxypyridinoline in healthy children and in children with growth hormone deficiency. J Clin Endocrinol Metab 1995; 80: 1922-1928.
11. Tapanainen P, Knip M, Risteli L, Kemppainen L, Kaar ML, Risteli J. Collagen metabolites in the prediction of response to GH therapy in short children. Eur J Endocrinol 1997; 137: 621-625.
12. Sartorio A, Conti A, Biella O, Arosio M. Bone turnover in children with growth disorders and in adults with GH deficiency. Acta Med Auxol 1996; 28: 39-46.
13. Phillip M, Hershkovitz E, Limoni Y, Leiberman E, Belotserkovsky O, Douvdevani A, Weber D. An early rise in urine N-telopeptide predicts the growth response of normal prepubertal short children to growth hormone therapy. J Pediatr Endocrinol Metab 1996; 9: 519-521.
14. Sartorio A, Conti A, Monzani M, Faglia G. Galanin infusion restores the blunted GH responses to GHRH administration during GH treatment in children with constitutional growth delay. J Endocrinol Invest 1995; 18: 109-112.
15. Hoopwood NJ, Hintz RL, Gertner JM, Atlie KM, Johanson AJ, Baptista J, Kuntze J, Blizzard RM, Cara JF, Chemausek SD, Kaplan SL, Lippe BM, Plotnick LP, Saenger P. Growth hormone response of children with non-growth hormone deficiency and marked short stature during three years of growth hormone therapy. J Pediatr 1993; 123: 215-222.
16. Zadik Z, Chalew S, Zung A, Landau H, Leiberman E, Koren R, Voet H, Hochberg Z, Kowarski AA. Effect of long-term growth hormone therapy on bone age and pubertal maturation in boys with and without classic growth hormone deficiency. J Pediatr 1994; 125: 189-195.
17. Loche S, Cambrasio P, Setzu S, Carta D, Marini R, Borrelli P, Cappa M. Final height after growth hormone therapy in non-growth hormone deficient children with short stature. J Pediatr 1994; 125: 196-200.
18. Low LCK, Kwan E, Karlberg J. A partial transient effect of short-term growth hormone (GH) treatment in short non-GH deficient prepubertal children. J Pediatr Endocrinol Metab 1995; 8: 173-179.
19. Lanes R. Effects of two years of growth hormone treatment in short, slowly growing non-growth hormone deficient children. J Pediatr Endocrinol Metab 1995; 8: 167-171.
20. Conti A, Ferrero S, Giambona S, Sartorio A. Urinary free deoxypyridinoline levels during childhood. J Endocrinol Invest 1998; 21: 318-322.